Cargando…

Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations

Telomerase reactivation and immortalization are critical for human carcinoma progression. However, little is known about the mechanisms controlling this crucial step, due in part to the paucity of experimentally tractable model systems that can examine human epithelial cell immortalization as it mig...

Descripción completa

Detalles Bibliográficos
Autores principales: Garbe, James C, Vrba, Lukas, Sputova, Klara, Fuchs, Laura, Novak, Petr, Brothman, Arthur R, Jackson, Mark, Chin, Koei, LaBarge, Mark A, Watts, George, Futscher, Bernard W, Stampfer, Martha R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613853/
https://www.ncbi.nlm.nih.gov/pubmed/25485586
http://dx.doi.org/10.4161/15384101.2014.954456
_version_ 1782396331208212480
author Garbe, James C
Vrba, Lukas
Sputova, Klara
Fuchs, Laura
Novak, Petr
Brothman, Arthur R
Jackson, Mark
Chin, Koei
LaBarge, Mark A
Watts, George
Futscher, Bernard W
Stampfer, Martha R
author_facet Garbe, James C
Vrba, Lukas
Sputova, Klara
Fuchs, Laura
Novak, Petr
Brothman, Arthur R
Jackson, Mark
Chin, Koei
LaBarge, Mark A
Watts, George
Futscher, Bernard W
Stampfer, Martha R
author_sort Garbe, James C
collection PubMed
description Telomerase reactivation and immortalization are critical for human carcinoma progression. However, little is known about the mechanisms controlling this crucial step, due in part to the paucity of experimentally tractable model systems that can examine human epithelial cell immortalization as it might occur in vivo. We achieved efficient non-clonal immortalization of normal human mammary epithelial cells (HMEC) by directly targeting the 2 main senescence barriers encountered by cultured HMEC. The stress-associated stasis barrier was bypassed using shRNA to p16(INK4); replicative senescence due to critically shortened telomeres was bypassed in post-stasis HMEC by c-MYC transduction. Thus, 2 pathologically relevant oncogenic agents are sufficient to immortally transform normal HMEC. The resultant non-clonal immortalized lines exhibited normal karyotypes. Most human carcinomas contain genomically unstable cells, with widespread instability first observed in vivo in pre-malignant stages; in vitro, instability is seen as finite cells with critically shortened telomeres approach replicative senescence. Our results support our hypotheses that: (1) telomere-dysfunction induced genomic instability in pre-malignant finite cells may generate the errors required for telomerase reactivation and immortalization, as well as many additional “passenger” errors carried forward into resulting carcinomas; (2) genomic instability during cancer progression is needed to generate errors that overcome tumor suppressive barriers, but not required per se; bypassing the senescence barriers by direct targeting eliminated a need for genomic errors to generate immortalization. Achieving efficient HMEC immortalization, in the absence of “passenger” genomic errors, should facilitate examination of telomerase regulation during human carcinoma progression, and exploration of agents that could prevent immortalization.
format Online
Article
Text
id pubmed-4613853
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-46138532015-10-29 Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations Garbe, James C Vrba, Lukas Sputova, Klara Fuchs, Laura Novak, Petr Brothman, Arthur R Jackson, Mark Chin, Koei LaBarge, Mark A Watts, George Futscher, Bernard W Stampfer, Martha R Cell Cycle Reports Telomerase reactivation and immortalization are critical for human carcinoma progression. However, little is known about the mechanisms controlling this crucial step, due in part to the paucity of experimentally tractable model systems that can examine human epithelial cell immortalization as it might occur in vivo. We achieved efficient non-clonal immortalization of normal human mammary epithelial cells (HMEC) by directly targeting the 2 main senescence barriers encountered by cultured HMEC. The stress-associated stasis barrier was bypassed using shRNA to p16(INK4); replicative senescence due to critically shortened telomeres was bypassed in post-stasis HMEC by c-MYC transduction. Thus, 2 pathologically relevant oncogenic agents are sufficient to immortally transform normal HMEC. The resultant non-clonal immortalized lines exhibited normal karyotypes. Most human carcinomas contain genomically unstable cells, with widespread instability first observed in vivo in pre-malignant stages; in vitro, instability is seen as finite cells with critically shortened telomeres approach replicative senescence. Our results support our hypotheses that: (1) telomere-dysfunction induced genomic instability in pre-malignant finite cells may generate the errors required for telomerase reactivation and immortalization, as well as many additional “passenger” errors carried forward into resulting carcinomas; (2) genomic instability during cancer progression is needed to generate errors that overcome tumor suppressive barriers, but not required per se; bypassing the senescence barriers by direct targeting eliminated a need for genomic errors to generate immortalization. Achieving efficient HMEC immortalization, in the absence of “passenger” genomic errors, should facilitate examination of telomerase regulation during human carcinoma progression, and exploration of agents that could prevent immortalization. Taylor & Francis 2014-10-29 /pmc/articles/PMC4613853/ /pubmed/25485586 http://dx.doi.org/10.4161/15384101.2014.954456 Text en © 2014 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Reports
Garbe, James C
Vrba, Lukas
Sputova, Klara
Fuchs, Laura
Novak, Petr
Brothman, Arthur R
Jackson, Mark
Chin, Koei
LaBarge, Mark A
Watts, George
Futscher, Bernard W
Stampfer, Martha R
Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations
title Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations
title_full Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations
title_fullStr Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations
title_full_unstemmed Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations
title_short Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations
title_sort immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations
topic Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613853/
https://www.ncbi.nlm.nih.gov/pubmed/25485586
http://dx.doi.org/10.4161/15384101.2014.954456
work_keys_str_mv AT garbejamesc immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations
AT vrbalukas immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations
AT sputovaklara immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations
AT fuchslaura immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations
AT novakpetr immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations
AT brothmanarthurr immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations
AT jacksonmark immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations
AT chinkoei immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations
AT labargemarka immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations
AT wattsgeorge immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations
AT futscherbernardw immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations
AT stampfermarthar immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations